体外诊断产品脂血干扰消除策略及评价方法Mitigation Strategies and Evaluation Methods for Lipemia Interference in In Vitro Diagnostic Products
冀俞蓉,尹小凡
摘要(Abstract):
抗脂血干扰性能是体外诊断产品设计开发过程的核心指标。该文简单介绍了脂血样本的产生原因及干扰途径;总结了目前公开的常见抗脂血干扰方法,包括广泛接受的超速离心、样本稀释,以及近年来逐渐应用的试剂配方调整、测量程序优化等;最后结合美国临床实验室标准化协会(CLSI)最新发表的EP07《临床化学中的干扰测试》及中华人民共和国医药行业标准YY/T 1 789.5—2023《体外诊断检验系统性能评价方法第5部分:分析特异性》中的要求,系统讨论了脂血干扰标准化评价方法。
关键词(KeyWords): 脂血干扰;超速离心;试剂配方;测量分析程序;脂血干扰评价
基金项目(Foundation):
作者(Author): 冀俞蓉,尹小凡
参考文献(References):
- [1]Fernández Prendes C,Castro Castro M J,Sánchez navarro L,et al.Handling of lipemic samples in the clinical laboratory[J].Adv Lab Med,2023,4(1):5-27.
- [2]Soh S X,Loh T P,Sethi S K,et al.Methods to reduce lipemic interference in clinical chemistry tests:a systematic review and recommendations[J].Clin Chem Lab Med,2022,60(2):152-161.
- [3]Koch C D,Vera M A,Messina J,et al.Preventing pseudohyponatremia:Intralipid??-based lipemia cutoffs for sodium are inappropriate[J].Clin Chim Acta,2021,520:63-66.
- [4]Farrell C J,Carter A C.Serum indices:managing assay interference[J].Ann Clin Biochem,2016,53(5):527-538.
- [5]Mccarron E P,Murray E,Mckeeman G C,et al.Investigating the effects of endogenous lipaemia on the measurement of sodium by indirect ion specific electrode potentiometry[J].Ann Clin Biochem,2022,59(5):324-329.
- [6]Saracevic A,Dukic L,Simundic A M.Haemolysis and lipemia interfere with resistin and myeloperoxidase BioVendor ELISA assays[J].Biochem Med(Zagreb),2019,29(2):020703.
- [7]Nikolac N.Lipemia:causes,interference mechanisms,detection and management[J].Biochem Med(Zagreb),2014,24(1):57-67.
- [8]Nordestgaard B G,Langsted A,Mora S,et al.Fasting is not routinely required for determination of a lipid profile:clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine[J].Eur Heart J,2016,37(25):1944-1958.
- [9]Mainali S,Davis S R,Krasowski M D.Frequency and causes of lipemia interference of clinical chemistry laboratory tests[J].Pract Lab Med,2017,8:1-9.
- [10]CLSI C56-A Hemolysis,icterus,and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis;Approved guideline[S].
- [11]郴州市第一人民医院.一种消减脂血标本血脂干扰的方法:CN202310765318.8[P].2023-10-20.
- [12]Castro-castro M J,Candás-estébanez B,Esteban-salán M,et al.Removing lipemia in serum/plasma samples:a multicenter study[J].Ann Lab Med,2018,38(6):518-523.
- [13]Roberts C M,Cotten S W.Cyclodextrin removal of lipemic interference:an attractive alternative to ultracentrifugation for satellite laboratories[J].Arch Pathol Lab Med,2013,137(8):1027-1028.
- [14]深圳迈瑞生物医疗电子股份有限公司.可抗脂血干扰的血液样本检测试剂盒及方法:CN201811321008.2[P].2020-05-15.
- [15]北京万泰德瑞诊断技术有限公司.一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原Ⅰ检测试剂盒:CN201410010750.7[P].2015-10-14.
- [16]北京万泰德瑞诊断技术有限公司.一种消除乳糜干扰的胶乳免疫比浊法胃蛋白酶原Ⅱ检测试剂盒:CN201410010900.4[P].2015-11-11.
- [17]武汉生之源生物科技股份有限公司.消除血清脂类干扰的胶乳免疫比浊法胃蛋白酶原Ⅱ检测试剂盒及其制备方法:CN201810289784.2[P].2021-03-19.
- [18]Xu Xiaoping,Cai Shuqian,Xue Junchi,et al.Highspeed centrifugation fails to mitigate severe lipemic interference in D-dimer measurement[J].Int J Lab Hematol,2025,47(5):906-914.
- [19]Zhu Jianhui,Lan Xuhong,Liang Xianming,et al.The method of lipemia clearance should be based on the characteristics and the method of testing in the emergency laboratory[J].Clin Lab,2024,70(8):1-7.
- [20]Soleimani N,Mohammadzadeh S,Asadian F.Lipemia interferences in biochemical tests,investigating the efficacy of different removal methods in comparison with ultracentrifugation as the gold standard[J].J Anal Methods Chem,2020:9857636.
- [21]Andrade N N N,Oliveira M V,Souza C L.Procedures to minimize interference of hypertriglyceridemia in laboratory exams of lipemic samples in acute pancreatitis:a case report[J].J Bras Patol Med Lab,2016,52(2):103-106.
- [22]中生北控生物科技股份有限公司.抗乳糜干扰的尿酸测定试剂盒:CN202011535494.5[P].2022-03-04.
- [23]中生北控生物科技股份有限公司.一种消除脂血样本中乳糜干扰的方法和免疫浊度法试剂盒及应用:CN202011531531.5[P].2021-06-18.
- [24]潍坊市康华生物技术有限公司.一种消除乳糜干扰的甘胆酸的检测试剂盒:CN201610784064.4[P].2016-11-16.
- [25]深圳迈瑞生物医疗电子股份有限公司,北京深迈瑞医疗电子技术研究院有限公司.一种抗干扰检测方法及样本分析仪:CN202080086434.1[P].2022-07-22.
- [26]深圳迈瑞生物医疗电子股份有限公司.一种干扰检测方法及样本分析仪:CN201811640155.6[P].2024-05-31.
- [27]深圳迈瑞生物医疗电子股份有限公司.样本分析仪及其检测方法:CN202311287603.X[P].2024-04-02.
- [28]Roche Diagnostics Operations,Inc..Multi-application approach for photometric determination of an analyte in a fluid sample on an automated analyzer:US201414524700A[P].2018-11-20.
- [29]Soleimani N,Dehghani S,Anbardar M H,et al.Comparing jaffe and enzymatic methods for creatinine measurement at various icterus levels and their impacts on liver transplant allocation[J].Int J Anal Chem,2023:9804533.
- [30]Arulvijayavani S,Mohanraj P S,Reeta R.Evaluating interference of lipemia on routine clinical biochemical tests[J].J Lab Physicians,2023,15(2):269-275.
- [31]De Baerdemaeker K,Foxton E,Wood D M,et al.Intravenous lipid emulsion interference in coagulation testing:an ex vivo analysis[J].Clin Toxicol(Phila),2024,62(7):441-445.
- [32]Xie Heying,Jia Yin,Liu Shanrong.Integration of artificial intelligence in clinical laboratory medicine:advancements and challenges[J].Interdisc Med,2024,2(3):e20230056.
- [33]Nikolac N,Simundic A M,Miksa M,et al.Heterogeneity of manufacturers'declarations for lipemia interferencean urgent call for standardization[J].Clin Chim Acta,2013,426:33-40.
- [34]CLSI EP07-3rd Edition Interference testing in clinical chemistry[S].
- [35]Li Min,Jiang Ruiwei,Wang Enyun,et al.Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2neutralizing antibody after vaccination in real world[J].BMC Infect Dis,2022,22(1):157.
- [36]Helmke S M,Mcrae M P,Christians U,et al.Avalidated LC-MS/MS assay for the quantification of cholate isotopes in human serum[J].J Appl Lab Med,2024,9(6):1028-39.
- [37]Johnson A M,Dudek J M,Edwards D K,et al.Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma[J].Expert Rev Mol Diagn,2021,21(11):1245-1252.
- [38]YY/T 1789.5-2023体外诊断检验系统性能评价方法第5部分:分析特异性[S].
- [39]CLSI EP07-A2 Interference testing in clinical chemistry;Approved guideline-second edition[S].
- [40]Karin A,Higgins V,Miller J,et al.Evaluation of hemolysis,lipemia,and icterus interference with common clinical immunoassays[J].Clin Chem Lab Med,2023,61(6):1035-1045.
- [41]Zheng Yuzi,Pearce R W,Mcshane A J.Lipemia interference for ALT and AST:effect from native lipid and commercial lipid emulsion-supplemented samples[J].J Appl Lab Med,2020,5(4):817-819.
- [42]??olak Samsum E,Sürer H,Bolat S,et al.Comparison of lipemia interference created with native lipemic material and intravenous lipid emulsion in emergency laboratory tests[J].Biochem Med(Zagreb),2024,34(2):020701.
- [43]Lee J H,Do Seo J,Lee K,et al.Multicenter comparison of analytical interferences of 25-OH vitamin D immunoassay and mass spectrometry methods by endogenous interferents and cross-reactivity with 3-epi-25-OH-vitamin D3[J].Pract Lab Med,2024,38:e00347.
- [44]Cho S E,Han J,You J,et al.Development and validation of a novel isotope dilution-ultraperformance liquid chromatography-tandem mass spectrometry method for serum c-peptide[J].Ann Lab Med,2025,45(1):62-69.
- [45]Deng Yuhang,Zhang Chao,Wang Jing,et al.An accurate isotope dilution liquid chromatography-tandem mass spectrometry method for serum C-peptide and its use in harmonization in China[J].Ann Lab Med,2023,43(4):345-354.
- [46]Nah H,Lee S G,Lee K S,et al.Evaluation of bilirubin interference and accuracy of six creatinine assays compared with isotope dilution-liquid chromatography mass spectrometry[J].Clin Biochem,2016,49(3):274-281.
- [47]Yan J,Lin H,Xu Y,et al.Measurement of serum uric acid by isotope dilution liquid chromatography tandem mass spectrometry:modification of a candidate reference measurement method and its clinical application[J].Int J Mass Spectrom,482,116911.
- [48]WS/T 413-2013血清肌酐测定参考方法同位素稀释液相色谱串联质谱法[S].
- [49]WS/T 478-2015血清25-羟基维生素D3检测操作指南同位素稀释液相色谱串联质谱法[S].
- [50]西门子医学诊断产品有限责任公司.制备用于确定脂质干扰的脂血血浆或血清样本:CN201710789597.6[P].2021-11-23.